MX2022011832A - Compuestos terpenofenolicos y su uso. - Google Patents
Compuestos terpenofenolicos y su uso.Info
- Publication number
- MX2022011832A MX2022011832A MX2022011832A MX2022011832A MX2022011832A MX 2022011832 A MX2022011832 A MX 2022011832A MX 2022011832 A MX2022011832 A MX 2022011832A MX 2022011832 A MX2022011832 A MX 2022011832A MX 2022011832 A MX2022011832 A MX 2022011832A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- cbd
- ene
- tetrahydro
- prop
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000003814 drug Substances 0.000 abstract 2
- YLCRFGSUAXVEKR-LEWJYISDSA-N CC=1CC[C@H]([C@@H](C=1)C=1C(=C(C=CC=1O)CCC1=CC=CC=C1)O)C(=C)C Chemical compound CC=1CC[C@H]([C@@H](C=1)C=1C(=C(C=CC=1O)CCC1=CC=CC=C1)O)C(=C)C YLCRFGSUAXVEKR-LEWJYISDSA-N 0.000 abstract 1
- QLPVCOQUNQFEAZ-LEWJYISDSA-N OC1=CC=C(C=C1)CCC=1C=C(C(=C(C=1)O)[C@H]1[C@@H](CCC(=C1)C)C(=C)C)O Chemical compound OC1=CC=C(C=C1)CCC=1C=C(C(=C(C=1)O)[C@H]1[C@@H](CCC(=C1)C)C(=C)C)O QLPVCOQUNQFEAZ-LEWJYISDSA-N 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/32—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions without formation of -OH groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/38—Alcohols containing six-membered aromatic rings and other rings and having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/001—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain
- C07C37/003—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain by hydrogenation of an unsaturated part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/11—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
- C07C37/14—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by addition reactions, i.e. reactions involving at least one carbon-to-carbon unsaturated bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003270P | 2020-03-31 | 2020-03-31 | |
| PCT/GB2021/050812 WO2021198692A1 (en) | 2020-03-31 | 2021-03-31 | Terpenophenolic compounds and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022011832A true MX2022011832A (es) | 2023-03-03 |
Family
ID=75426633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022011832A MX2022011832A (es) | 2020-03-31 | 2021-03-31 | Compuestos terpenofenolicos y su uso. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12552733B2 (https=) |
| EP (1) | EP4126800A1 (https=) |
| JP (1) | JP7714571B2 (https=) |
| KR (1) | KR20230121960A (https=) |
| CN (1) | CN116194431B (https=) |
| AU (1) | AU2021248627A1 (https=) |
| BR (1) | BR112022019616A2 (https=) |
| CA (1) | CA3177186A1 (https=) |
| GB (2) | GB2609814B (https=) |
| IL (1) | IL296861A (https=) |
| MX (1) | MX2022011832A (https=) |
| WO (1) | WO2021198692A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3179235A1 (en) * | 2019-05-23 | 2020-11-26 | Kare Chemical Technologies Inc. | Catalytic cannabinoid processes and precursors |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL136839A (en) * | 2000-06-16 | 2006-12-10 | Yissum Res Dev Co | Pharmaceutical compositions comprising cannabidiol derivatives, and processes for the preparation of same |
| CA2623723A1 (en) | 2005-09-29 | 2007-04-12 | Amr Technology, Inc. | Process for production of delta-9-tetrahydrocannabinol |
| DK2176208T3 (en) * | 2007-07-30 | 2015-04-27 | Zynerba Pharmaceuticals Inc | Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof |
| DE102009019322A1 (de) * | 2009-04-30 | 2010-11-11 | The Health Concept Gmbh | Verfahren zur Herstellung von Synthetischen Cannabinoiden |
| TWI583374B (zh) * | 2010-03-30 | 2017-05-21 | Ｇｗ伐瑪有限公司 | 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途 |
| WO2014177593A1 (en) | 2013-04-29 | 2014-11-06 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Amorfrutin analogs as ppargamma-modulators |
| US9526706B1 (en) | 2015-06-16 | 2016-12-27 | Hong Kong Baptist University | Method of using dihydro-resveratrol for treating acute pancreatitis and associated pulmonary injury |
| US9738581B2 (en) * | 2015-06-16 | 2017-08-22 | Hong Kong Baptist University | Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions |
| US10059683B2 (en) | 2015-07-10 | 2018-08-28 | Noramco, Inc. | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol |
| AU2017250303B2 (en) | 2016-04-15 | 2019-09-26 | Teewinot Technologies Limited | Biosynthesis of cannabinoid prodrugs |
| JP2019523228A (ja) | 2016-06-16 | 2019-08-22 | ティーウィノット テクノロジーズ リミテッド | カンナビノイドプロドラッグの製造のための方法、薬学的製剤、およびその使用 |
| US10640482B2 (en) | 2017-07-21 | 2020-05-05 | University Of South Florida | Synthesis of cannabinoids |
| SG11202001725SA (en) * | 2017-09-01 | 2020-03-30 | Pureform Global Inc | Synthetic cannabidiol compositions and methods of making the same |
| JP2021535203A (ja) * | 2018-08-20 | 2021-12-16 | ベッソール ファルマ、エルエルシー | 既知および新規カンナビノイドの適用 |
| CA3179235A1 (en) * | 2019-05-23 | 2020-11-26 | Kare Chemical Technologies Inc. | Catalytic cannabinoid processes and precursors |
| AU2020345656A1 (en) * | 2019-09-09 | 2022-04-21 | Kare Chemical Technologies Inc. | Cannabinoid derivatives, precursors and uses |
| WO2021046640A1 (en) * | 2019-09-10 | 2021-03-18 | Kare Chemical Technologies Inc. | Cannabinoid derivatives and precursors, and asymmetric synthesis for same |
-
2021
- 2021-03-31 BR BR112022019616A patent/BR112022019616A2/pt unknown
- 2021-03-31 GB GB2215746.5A patent/GB2609814B/en active Active
- 2021-03-31 MX MX2022011832A patent/MX2022011832A/es unknown
- 2021-03-31 US US17/916,494 patent/US12552733B2/en active Active
- 2021-03-31 KR KR1020227037909A patent/KR20230121960A/ko active Pending
- 2021-03-31 JP JP2022560311A patent/JP7714571B2/ja active Active
- 2021-03-31 GB GB2104690.9A patent/GB2595355A/en not_active Withdrawn
- 2021-03-31 AU AU2021248627A patent/AU2021248627A1/en active Pending
- 2021-03-31 EP EP21717177.6A patent/EP4126800A1/en active Pending
- 2021-03-31 WO PCT/GB2021/050812 patent/WO2021198692A1/en not_active Ceased
- 2021-03-31 CN CN202180038597.7A patent/CN116194431B/zh active Active
- 2021-03-31 IL IL296861A patent/IL296861A/en unknown
- 2021-03-31 CA CA3177186A patent/CA3177186A1/en active Pending
-
2022
- 2022-09-30 US US17/958,083 patent/US20230225985A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GB2595355A (en) | 2021-11-24 |
| GB202215746D0 (en) | 2022-12-07 |
| US20230227390A1 (en) | 2023-07-20 |
| CN116194431B (zh) | 2026-01-02 |
| BR112022019616A2 (pt) | 2022-12-06 |
| KR20230121960A (ko) | 2023-08-22 |
| WO2021198692A1 (en) | 2021-10-07 |
| JP7714571B2 (ja) | 2025-07-29 |
| GB2609814A (en) | 2023-02-15 |
| US12552733B2 (en) | 2026-02-17 |
| CA3177186A1 (en) | 2021-10-07 |
| US20230225985A1 (en) | 2023-07-20 |
| AU2021248627A1 (en) | 2022-12-01 |
| GB202104690D0 (en) | 2021-05-12 |
| IL296861A (en) | 2022-11-01 |
| EP4126800A1 (en) | 2023-02-08 |
| GB2609814B (en) | 2024-08-28 |
| JP2023520794A (ja) | 2023-05-19 |
| CN116194431A (zh) | 2023-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP1913A (en) | Substituted benzazoles and use thereof as raf kinase inhibitors | |
| WO2005039485A3 (en) | Gsk-3 inhibitors and uses thereof | |
| IL174965A0 (en) | SUBSTITUTED BENZAZOLES AND USE THEREOF AS INHIBITORS OF Raf KINASE | |
| GEP20043375B (en) | APRIL-Receptor (BCMA) and Use Thereof | |
| BG105830A (en) | C-21 modified epothilones | |
| WO2020016659A3 (en) | Multiparticulate formulations of cannabinoids | |
| TW200514580A (en) | Adhesive preparations | |
| MXPA04006181A (es) | Polvo farmaceutico o nutraceutico micronizado, con liberacion inmediata. | |
| WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
| SG127738A1 (en) | Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, pharmaceutical preparations containing these compounds | |
| MX9701553A (es) | Herbicidas selectivos a base de ariluracilos. | |
| UY28941A1 (es) | Indazoles sustituidos, composiciones que los contienen, procedimiento de preparacion y su uso | |
| EE05074B1 (et) | Sulfoonamiid- ja sulfamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid | |
| ZA200307161B (en) | Medical aerosol formulations | |
| GEP20063741B (en) | Nonaryl-Heterocyclic NMDA/NR2B Antagonists | |
| UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
| UA89315C2 (en) | Butylbenzene phthalein intravenous emulsion | |
| ATE286664T1 (de) | Pharmazeutische oder diätetische zusammensetzungen aus pilzen und deren verwendung | |
| TW200731971A (en) | Solid preparation | |
| WO2005009460A3 (en) | Pharmaceutical composition comprising activin a, alk-4 or derivatives thereof for the treatment of ophthalmic disorders or cancer | |
| MX2022011832A (es) | Compuestos terpenofenolicos y su uso. | |
| MX9300558A (es) | Nueva sulfonilurea, procedimiento para su preparacion y formulado farmaceutico que la contiene. | |
| DK1660100T3 (da) | Anti-tumorformuleringer der omfatter defibrotid alene eller i kombination med andre anti-tumormidler | |
| WO2004006911A3 (fr) | Compositions destinees au traitement des neuropathies peripheriques, preparation et utilisations | |
| SI1891961T1 (sl) | Uporaba 5'-metiltioadenozina (MTA) za preprečevanje in/ali zdravljenje avtoimunske bolezni in/ali transplantacijske zavrnitve |